ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 72 filers reported holding ESSA PHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,854 | +14.4% | 600 | 0.0% | 0.00% | – |
| Q2 2023 | $1,620 | -9.1% | 600 | 0.0% | 0.00% | – |
| Q1 2023 | $1,782 | +17.9% | 600 | 0.0% | 0.00% | – |
| Q4 2022 | $1,512 | +51.2% | 600 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | -50.0% | 600 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | -50.0% | 600 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $4,000 | -55.6% | 600 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $9,000 | +80.0% | 600 | 0.0% | 0.00% | +100.0% |
| Q3 2021 | $5,000 | -70.6% | 600 | 0.0% | 0.00% | -75.0% |
| Q2 2021 | $17,000 | 0.0% | 600 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $17,000 | +142.9% | 600 | 0.0% | 0.00% | +100.0% |
| Q4 2020 | $7,000 | +75.0% | 600 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $4,000 | 0.0% | 600 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $4,000 | +100.0% | 600 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $2,000 | -33.3% | 600 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $3,000 | +50.0% | 600 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $2,000 | +100.0% | 600 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | -50.0% | 600 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $2,000 | +100.0% | 600 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 8,748,629 | $15,923,000 | 0.66% |
| Soleus Capital Management, L.P. | 2,640,539 | $4,806,000 | 0.65% |
| Omega Fund Management, LLC | 328,196 | $597,000 | 0.22% |
| MPM BioImpact LLC | 405,700 | $738,000 | 0.18% |
| Bellevue Group AG | 5,898,583 | $10,736,000 | 0.15% |
| Rhenman & Partners Asset Management AB | 375,000 | $1,350,000 | 0.14% |
| PFM Health Sciences, LP | 1,478,252 | $2,690,000 | 0.10% |
| Frazier Life Sciences Management, L.P. | 692,910 | $1,261,000 | 0.10% |
| Avidity Partners Management LP | 2,460,000 | $4,477,000 | 0.09% |
| Eventide Asset Management | 1,561,251 | $2,841,000 | 0.06% |